Science Explorer Back to mapMap
Discussion
Researcher · Rockefeller University · United States

Daniel Mucida

Daniel Mucida publishes mostly in Immunology, Molecular Biology and Oncology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and IL-33, ST2, and ILC Pathways.

ORCID 0000-0002-0000-0452 OpenAlex
World rank
#22,681
of 7,710,434 ranked researchers
Rank in United States
#8,347
of 1,627,098
Works
167
Citations
20k
Citations per work
116.9
h-index
63
i10-index 82Top 2.2% in Immunology
Daniel Mucida

What does Daniel Mucida research?

Daniel Mucida's work is mostly in Immunology and Microbiology (51%), Medicine (12%), Biochemistry, Genetics and Molecular Biology (12%).

Life Sciences: 105 works · 63.0% of their workImmunology and Microbiology: 86 works · 51.3% of their workImmunology: 86 works · 51.3% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 11.7% of their workMolecular Biology: 20 works · 11.7% of their workEverything else: 41 works · 24.6% of their workHealth Sciences: 21 works · 12.4% of their workMedicine: 21 works · 12.4% of their workOncology: 6 works · 3.7% of their workPhysiology: 6 works · 3.3% of their workGastroenterology: 5 works · 2.8% of their workInfectious Diseases: 4 works · 2.6% of their workTHEIR WORKDaniel Mucida167works
Life Sciences63%Health Sciences12%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology8651.3%
    2. Biochemistry, Genetics and Molecular Biology2011.7%
  2. Everything else4124.6%
    1. Medicine2112.4%
  1. 1Immunology51% of their works
  2. 2Molecular Biology12% of their works
  3. 3Oncology4% of their works
  4. 4Physiology3% of their works
  5. 5Gastroenterology3% of their works
  6. 6Infectious Diseases3% of their works

Research topics

Which keywords describe Daniel Mucida's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, TGF-ß, Inflammatory Diseases, CD4+CD25+, Foxp3, Regulatory T Cells and IL-33.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. NK Cell Recognition681 topic
  2. Natural Killer Cells681 topic
  3. TGF-ß652 topics
  4. Inflammatory Diseases612 topics
  5. CD4+CD25+541 topic
  6. Foxp3541 topic
  7. Regulatory T Cells432 topics
  8. IL-33321 topic
  9. Innate Lymphoid Cells321 topic
  10. Gut Microbiota291 topic
  11. Microbial Communities291 topic
  12. Dendritic Cells261 topic
  13. Immunity261 topic
  14. Inflammation202 topics
  15. Gastrointestinal Disorders111 topic
  16. IL-17111 topic
  17. Irritable Bowel Syndrome111 topic
  18. TH17 Cells111 topic
  19. Pattern Recognition Receptors91 topic
  20. Toll-like Receptors91 topic

Where does Daniel Mucida work?

Daniel Mucida's main affiliation in the publication record is Rockefeller University, United States.

How many publications and citations does Daniel Mucida have?

OpenAlex counts 167 works and 19,521 citations for Daniel Mucida, an h-index of 63, ranking #22,681 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Daniel Mucida. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.